Gender Clinic Whistleblower Thought She Was Helping Kids but She Was Wrong | Jamie Reed (#49)
20 November 2025
With Jamie Reed
North America
Jamie Reed spent four years inside a US paediatric gender clinic before filing a detailed affidavit with state authorities. Her firsthand account of inadequate assessment, unchecked caseloads and ideologically driven care mirrors what the Cass Review documented in the NHS. Her testimony helped close the clinic's paediatric service and offers a rare insider perspective on how institutions committed to gender-identity medicine can lose sight of patient welfare — a pattern the UK has spent the past two years trying to correct.
Jamie Reed spent more than a decade working in HIV care before joining Washington University's Transgender Center at St. Louis Children's Hospital in 2018. She was, by any measure, a sympathetic hire: a lesbian with progressive politics, long experience in patient advocacy, and no prior scepticism about gender medicine. She had studied the WPATH Standards of Care before starting and believed, as she has since described it, that the clinicians running such centres knew what they were doing. Over four years as case manager and clinical research coordinator, that confidence eroded. Reed became the clinic's go-to contact for patients seeking legal name changes, support letters and gender marker adjustments. What she observed, however, went beyond administrative work. The affidavit she eventually filed described a service that was expanding rapidly, with patients moving onto medical pathways in ways she came to regard as insufficiently examined and potentially harmful. Her concerns found little purchase internally. In February 2023, Reed went public. She filed a 23-page affidavit with Missouri's Attorney General and published an account that circulated widely across the English-speaking world. Nineteen months later, the clinic ceased treating minors. The personal dimension of her story added further weight: her partner at the time was identifying as male when Reed went public, and detransitioned approximately two years later — a development she has addressed openly. The parallels with the United Kingdom are difficult to ignore. The Cass Review, published in April 2024 following a four-year independent examination of NHS gender services for children, reached strikingly similar conclusions about the quality of evidence underpinning paediatric gender medicine: that it was weak, that diagnostic and mental-health assessments had been inadequate, and that large numbers of young people had been placed on irreversible medical pathways without sufficient investigation of co-occurring needs. The Tavistock GIDS clinic was closed. NHS England subsequently restricted puberty blocker prescribing for gender dysphoria in under-18s to research settings only. The institutional trajectory Reed describes in Missouri is recognisable from the British experience. Reed now directs the LGB Courage Coalition and continues to document legal and policy developments in gender medicine across the United States. What her account offers — from someone who entered the field as a genuine advocate and left as a whistleblower — is a firsthand record of how clinical institutions can prioritise ideological commitments over rigorous patient care. Alongside formal reviews such as Cass, insider testimony of this kind has proved essential in establishing that the concerns raised about paediatric gender medicine were not marginal or politically motivated, but grounded in observable clinical reality.
